These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17689369)

  • 21. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.
    Day C; White B; Ross J; Dolan K
    Aust N Z J Public Health; 2003 Oct; 27(5):558. PubMed ID: 14651407
    [No Abstract]   [Full Text] [Related]  

  • 23. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia.
    Degenhardt L; Black E; Breen C; Bruno R; Kinner S; Roxburgh A; Fry C; Jenkinson R; Ward J; Fetherston J; Weekley J; Fischer J
    Drug Alcohol Rev; 2006 Sep; 25(5):403-12. PubMed ID: 16939934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A; Treloar C; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiators: an examination of young injecting drug users who initiate others to injecting.
    Bryant J; Treloar C
    AIDS Behav; 2008 Nov; 12(6):885-90. PubMed ID: 18097744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of a heroin overdose prevention and education campaign.
    Horyniak D; Higgs P; Lewis J; Winter R; Dietze P; Aitken C
    Drug Alcohol Rev; 2010 Jan; 29(1):5-11. PubMed ID: 20078676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug use and risk among regular injecting drug users in Australia: does age make a difference?
    Degenhardt L; Kinner SA; Roxburgh A; Black E; Bruno R; Fetherston J; Fry CL
    Drug Alcohol Rev; 2008 Jul; 27(4):357-60. PubMed ID: 18584384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staying safe from hepatitis C: engaging with multiple priorities.
    Harris M; Treloar C; Maher L
    Qual Health Res; 2012 Jan; 22(1):31-42. PubMed ID: 21873284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injecting drug users' understanding of hepatitis C.
    O'Brien S; Day C; Black E; Dolan K
    Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.
    Rhodes T; Treloar C
    Addiction; 2008 Oct; 103(10):1593-603. PubMed ID: 18821870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition to and from injecting drug use among regular ecstasy users.
    Dunn M; Degenhardt L; Bruno R
    Addict Behav; 2010 Oct; 35(10):909-12. PubMed ID: 20587367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
    Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk and benefit perceptions of party drug use.
    White B; Degenhardt L; Breen C; Bruno R; Newman J; Proudfoot P
    Addict Behav; 2006 Jan; 31(1):137-42. PubMed ID: 15907371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Education by peers is the key to success.
    Galindo L; Maginnis T; Wallace G; Hansen A; Sylvestre D
    Int J Drug Policy; 2007 Oct; 18(5):411-6. PubMed ID: 17854730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia.
    Nathani J; Iversen J; Shying K; Byrne J; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):413-9. PubMed ID: 20636658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing hepatitis C: what do positive injectors do?
    Carruthers SJ
    Drug Alcohol Rev; 2005 Mar; 24(2):193-8. PubMed ID: 16076589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.